By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the ...

Senior medical analyst Dr. Marc Siegel joined 'Fox & Friends' to discuss Wegovy's launch of the first GLP-1 pill to fight ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

Nick Reiner's weight gain set him on a murderous path, but it didn't have to be that way ... just ask Dr. Drew.

Weight loss drugs like Ozempic and Wegovy have had a meteoric rise in recent years, but how fast does the weight return after ...